The cardioprotective effect of urocortin during ischaemia/reperfusion involves the prevention of mitochondrial damage

This publication has 31 references indexed in Scilit:

• Urocortin protects cardiac myocytes from ischemia/reperfusion injury by attenuating calcium insensitive phospholipase A₂gene expression
  The FASEB Journal, 2003
• Activation of Protein Kinase B/Akt by Urocortin is Essential for its Ability to Protect Cardiac Cells Against Hypoxia/Reoxygenation-induced Cell Death
  Journal of Molecular and Cellular Cardiology, 2002
• Urocortin
  The International Journal of Biochemistry & Cell Biology, 2002
• Expression of Activated PKC Epsilon (PKC ϵ) Protects the Ischemic Heart, without Attenuating Ischemic H+ Production
  Journal of Molecular and Cellular Cardiology, 2002
• Urocortin Protects against Ischemic and Reperfusion Injury via a MAPK-dependent Pathway
  Published by Elsevier ,2000
• Lysophosphatidylcholine, a Metabolite which Accumulates Early in Myocardium During Ischemia, Reduces Gap Junctional Coupling in Cardiac Cells
  Journal of Molecular and Cellular Cardiology, 1999
• Kir6.1: A Possible Subunit of ATP-Sensitive K+Channels in Mitochondria
  Biochemical and Biophysical Research Communications, 1997
• A New Approach to the Development of Anti-ischemic Drugs. Substances that Counteract the Deleterious Effect of Lysophosphatidylcholine on the Heart.
  Japanese Heart Journal, 1997
• Lysophospholipids modulate channel function by altering the mechanical properties of lipid bilayers.
  The Journal of general physiology, 1994
• Modulation of cardiac sodium channel gating by lysophosphatidylcholine
  Journal of Molecular and Cellular Cardiology, 1991